ADIGENS HEALTH LIMITED

Adigens Health is a founder‑led partner for life‑sciences companies, helping them turn real‑world data into clear, actionable strategies that accelerate clinical development and ready assets for launch. By simplifying the complexities of evidence generation, the firm works hand‑in‑hand with its clients to align clinical plans with market needs, optimise indication and development pathways, and deliver results that stand up to regulatory and health‑technology assessment scrutiny.

The company’s core specialisations include target trial emulation with external controls, real‑world evidence (RWE) strategies for regulators and HTAs, and RWE‑driven trial design covering endpoints, dose selection and comparators. Their multidisciplinary approach draws on the diverse expertise of the founders, ensuring hands‑on guidance throughout every engagement.

Adigens Health serves pharmaceutical and medical‑device developers seeking innovative, evidence‑based solutions that meet the highest decision‑making standards. Their focus on rigorous, adoption‑ready results makes them a trusted ally for organisations aiming to bridge the gap between trial outcomes and real‑world practice.